Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F San Miguel

Showing results (1-10 of 329) with videos related to

Pageof 33
Sort By:
Sangre|August 1, 1996
[The hematology laboratory in the study of malignant blood diseases. Introduction]J F San Miguel Izquierdo
American Journal of Hematology|June 1, 1987
T-cell subsets and myeloma cell massJ F San Miguel, M González
Sangre|January 1, 1984
[Monoclonal gammopathies: classical parameters and beta 2 microglobulins in the differential diagnosis]F Ortega, J F San Miguel
Best Practice & Research. Clinical Haematology|December 12, 2007
Bortezomib in multiple myelomaM V Mateos, J F San Miguel
Leukemia Supplements|May 14, 2016
Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantationJ F San Miguel, M-V Mateos
Sangre|January 1, 1984
[Prognostic factors and stages in multiple myeloma]J M Hernández, J F San Miguel
Medical Oncology (Northwood, London, England)|October 24, 1998
Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphomaJ F San Miguel, R García-Sanz
Mayo Clinic Proceedings|July 1, 1994
Cell surface markers in multiple myelomaG J Ruiz-Argüelles, J F San Miguel
Medicina Clinica|March 5, 1983
[Membrane markers in chronic lymphoproliferative diseases]E Matutes, J F San Miguel, D Catovsky
British Journal of Cancer|January 1, 1989
Prognostic factors and classification in multiple myelomaJ F San Miguel, J Sànchez, M Gonzalez
Pageof 33

Showing results (1-10 of 329) with videos related to

Sort By:
Pageof 33
Sangre|August 1, 1996
[The hematology laboratory in the study of malignant blood diseases. Introduction]J F San Miguel Izquierdo
American Journal of Hematology|June 1, 1987
T-cell subsets and myeloma cell massJ F San Miguel, M González
Sangre|January 1, 1984
[Monoclonal gammopathies: classical parameters and beta 2 microglobulins in the differential diagnosis]F Ortega, J F San Miguel
Best Practice & Research. Clinical Haematology|December 12, 2007
Bortezomib in multiple myelomaM V Mateos, J F San Miguel
Leukemia Supplements|May 14, 2016
Advances in treatment for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantationJ F San Miguel, M-V Mateos
Sangre|January 1, 1984
[Prognostic factors and stages in multiple myeloma]J M Hernández, J F San Miguel
Medical Oncology (Northwood, London, England)|October 24, 1998
Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphomaJ F San Miguel, R García-Sanz
Mayo Clinic Proceedings|July 1, 1994
Cell surface markers in multiple myelomaG J Ruiz-Argüelles, J F San Miguel
Medicina Clinica|March 5, 1983
[Membrane markers in chronic lymphoproliferative diseases]E Matutes, J F San Miguel, D Catovsky
British Journal of Cancer|January 1, 1989
Prognostic factors and classification in multiple myelomaJ F San Miguel, J Sànchez, M Gonzalez
Pageof 33